Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Maryland Tech Journal.
Press releases published on August 12, 2025

GAMA-1 Technologies Earns 2025 Great Place To Work Certification™ for Fifth Year
96% of employees say GAMA-1 Technologies is a great place to work, far surpassing the national average. GREENBELT, MD, UNITED STATES, August 12, 2025 /EINPresswire.com/ -- GAMA-1 Technologies, a certified Small Disadvantaged Business and trusted federal …

Fasoo Smart Print Enhances Enterprise Print Security and Compliance Across Regulated Industries
BETHESDA , MD, UNITED STATES, August 12, 2025 /EINPresswire.com/ -- — Fasoo, the leader in data-centric security, today announced growing momentum for Fasoo Smart Print, its innovative print security solution, across industries handling sensitive and …

Acceleware Ltd. Announces Extension of Private Placement Financing
CALGARY, Alberta, Aug. 12, 2025 (GLOBE NEWSWIRE) -- Acceleware® Ltd. (“Acceleware” or the “Company”) (TSX-V: AXE), a leading innovator of cutting-edge radio frequency (“RF”) power-to-heat technologies targeting process heat for critical minerals, amine …

ZenaTech reporta un aumento de más del 500 % en los ingresos interanuales del segundo trimestre de 2025 y de más del 250 % en los ingresos del primer semestre del año
VANCOUVER, Columbia Británica, Aug. 12, 2025 (GLOBE NEWSWIRE) -- ZenaTech, Inc. (Nasdaq: ZENA) (FSE: 49Q) (BMV: ZENA) ("ZenaTech"), proveedor de soluciones empresariales tecnológicas especializado en drones con inteligencia artificial (IA), Drones como …

Signing Day Sports Announces Selected Financial Results for Quarter Ended June 30, 2025, and Provides Business Update
SCOTTSDALE, AZ, Aug. 12, 2025 (GLOBE NEWSWIRE) -- Signing Day Sports, Inc. (“Signing Day Sports” or the “Company”) (NYSE American: SGN), the developer of the Signing Day Sports app and platform to aid high school athletes in the recruitment process, today …

Satellogic Reports Second Quarter Financial Results
27% Increase in Revenue to $4.4 million Coupled with 41% Decrease in Operating Costs and Expenses in 2Q 2025 Poised to Deliver NextGen Satellite and Technology Transfer to Malaysia’s Earth Observation Satellite Program Awarded $30 Million Contract for AI- …

Eupraxia Pharmaceuticals Reports Second Quarter 2025 Financial Results and Provides Business Update
Announced first patient dosed in the Phase 2b placebo-controlled portion of the EP-104GI RESOLVE trial with topline data expected in H2 2026 Announced positive data from Phase 1b/2a RESOLVE supporting the potential of EP-104GI to improve the standard of …

Inspired Launches V-Play Football Brazil with EstrelaBet via the Altenar Sportsbook
NEW YORK, Aug. 12, 2025 (GLOBE NEWSWIRE) -- Inspired Entertainment, Inc. (“Inspired” or the “Company”) (NASDAQ: INSE), a leading B2B provider of gaming content, technology, hardware, and services, is pleased to announce the launch of V-Play Football Brazil …

PubMatic to Participate in Upcoming Financial Conferences
NO-HEADQUARTERS/REDWOOD CITY, Calif., Aug. 12, 2025 (GLOBE NEWSWIRE) -- PubMatic, Inc. (Nasdaq: PUBM), an independent technology company delivering digital advertising’s supply chain of the future, today announced that members of its management team are …

vTv Therapeutics Reports Second Quarter 2025 Financial Results and Provides Corporate Update
• First study participant randomized in Phase 3 CATT1 trial evaluating cadisegliatin for the treatment of type 1 diabetes with data expected in second half of 2026 • Cadisegliatin intellectual property portfolio expanded • Leadership team …

Urgently Announces Second Quarter 2025 Financial Results
ASHBURN, Va., Aug. 12, 2025 (GLOBE NEWSWIRE) -- Urgent.ly Inc. (Nasdaq: ULY) (“Urgently”), a U.S.-based leading provider of digital roadside and mobility assistance technology and services, today reported financial results for the second quarter ended June …

ImmuCell Announces Bank Debt Refinancing
PORTLAND, Maine, Aug. 12, 2025 (GLOBE NEWSWIRE) -- ImmuCell Corporation (Nasdaq: ICCC) (“ImmuCell” or the “Company”), a growing animal health company that develops, manufactures and markets scientifically proven and practical products that improve the …

Rigetti Computing Reports Second Quarter 2025 Financial Results; Announces General Availability of its 36-Qubit Multi-Chip Quantum Computer
BERKELEY, Calif., Aug. 12, 2025 (GLOBE NEWSWIRE) -- Rigetti Computing, Inc. (Nasdaq: RGTI) (“Rigetti” or the “Company”), a pioneer in full-stack quantum-classical computing, today announced its financial results for the second quarter ended June 30, 2025. …

ARRAY Technologies, Inc. to Participate in Upcoming Investor Conferences and Events
ALBUQUERQUE, N.M., Aug. 12, 2025 (GLOBE NEWSWIRE) -- ARRAY Technologies (NASDAQ: ARRY) (“ARRAY” or the “Company”), a leading global provider of solar tracking technology products, software and services, today announced its attendance at the following …

Diginex Announces MOU for US$305m Acquisition of Findings, a leading cybersecurity and compliance automation company
LONDON, Aug. 12, 2025 (GLOBE NEWSWIRE) -- Diginex Limited (“Diginex” or the “Company”) (NASDAQ: DGNX), a leading provider of Sustainability RegTech solutions, today announced the signing of a non-binding Memorandum of Understanding (MOU) to acquire 100% of …

Cue Biopharma Reports Second Quarter 2025 Financial Results and Recent Business Highlights
Received FDA feedback on Pre-IND Briefing Document reinforcing Company’s intention to advance investigational new drug (IND) submission for CUE-401 to address unmet need in the treatment of autoimmune disease. Announced strategic research collaboration and …

AEON Biopharma Reports Second Quarter 2025 Financial Results and Provides Corporate Update
– Multiple near-term potential milestones, including anticipated completion of primary structure analysis and select functional analyses in 3Q’25 – – Type 2a meeting with the FDA anticipated in 4Q’25– – Cash runway expected to support operations through …

ALX Oncology Reports Second Quarter 2025 Financial Results and Provides Corporate Update
– Data from ASPEN-06 trial highlights CD47 expression as a key predictive biomarker of greater response to evorpacept in HER2+ Gastric Cancer; updated data to be presented at a medical conference in Q4 2025 – Phase 2 ASPEN-Breast evorpacept trial design …

Lyell Immunopharma Reports Business Highlights and Financial Results for the Second Quarter 2025
Presented positive new clinical data demonstrating high rates of durable complete responses from the Phase 1/2 trial of LYL314 for the treatment of aggressive large B-cell lymphoma Initiated the PiNACLE pivotal trial of LYL314 in patients with large B-cell …

Adagene Reports Six Months 2025 Financial Results and Provides Corporate Updates
Muzastotug (ADG126) Phase 1b/2 in MSS CRC shows 19.4-month median OS (mOS) in 10 mg/kg dose cohorts; mOS for 20 mg/kg cohorts has not yet been reached Alignment with FDA on Phase 2 and Phase 3 trial design elements. Company expects to begin enrolling …